FDA Adverse Event Malfunction Summary report: N

PROMUS ELEMENT ¿

MDR report key: 2946347 · Received February 6, 2013

Report

Report Number
2134265-2013-00762
Event Type
Malfunction
Date Received
February 6, 2013
Date of Event
November 12, 2012
Report Date
January 11, 2013
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
SIMILAR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. (B)(4). DEVICE EVALUATED BY MANUFACTURER: A VISUAL AND MICROSCOPIC EXAMINATION FOUND THAT THE STENT WAS DAMAGED AT THE DISTAL END WITH APPROXIMATELY TEN ROWS BEING MISALIGNED AND BUNCHED UP. NO OTHER ISSUES WERE NOTED WITH THE TIP AND BALLOON OF THE DEVICE THAT COULD HAVE POTENTIALLY CONTRIBUTED TO THE COMPLAINT INCIDENT. THE BALLOON WAS TIGHTLY WRAPPED AND WAS NOT SUBJECTED TO POSITIVE PRESSURE. NO KINKS OR DAMAGE WERE NOTICED ALONG THE SHAFT OF THE DEVICE. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

REPORTABLE BASED ON THE PRODUCT ANALYSIS COMPLETED ON (B)(4) 2013. IT WAS REPORTED THAT DURING A STENTING TREATMENT PROCEDURE, DIFFICULTY ADVANCING ACROSS THE LESION OCCURRED. THE TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS LEFT CIRCUMFLEX (LCX) ARTERY. THE PHYSICIAN ADVANCED A 3.5 X 16 MM PROMUS ELEMENT PLUS STENT TO THE LESION BUT COULD NOT CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH BALLOON ANGIOPLASTY. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT STATUS IS GOOD. HOWEVER, THE RETURNED PRODUCT ANALYSIS REVEALED STENT DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
51242 PROMUS ELEMENT ¿ STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493911324250 15534167

Patients

Seq Age Sex Outcome Treatment
1